DB15801InvestigationalVaccines
The bacille Calmette-Guérin (BCG) vaccine protects against severe extrapulmonary forms of tuberculosis (TB) but does not adequately protect against pulmonary TB -- the most prevalent form of TB. This recombinant... This recombinant BCG, VPM1002, has been created in response and investigated for preventing pulmonary TB in newborns and TB recurrence in adults through post-exposure immunization.
- Also known as
- BCG VPM1002 · rBCG · Recombinant BCG Vaccine
- Code names
- VPM1002
What you can answer from here — as of September 06, 2020
Which companies are running trials of VPM1002, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account